Eledon Pharma (NASDAQ:ELDN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Eledon Pharma (ELDN) operate in?

Eledon Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Eledon Pharma Stock (NASDAQ: ELDN) stock price, news, charts, stock research, profile.

Open	$2.63
Close	$2.64
Volume / Avg.	109.79K / 210.77K
Day Range	2.45 - 2.65
52 Wk Range	1.07 - 3.35
Market Cap	$96.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	0.16%
Days to Cover	1

Recent News

Nano-Cap Eledon Pharmaceuticals' Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.

Vandana Singh

Kidney Transplant From Genetically Edited Pig: Boston Patient With End-Stage Renal Disease Becomes First To Receive

Eledon Pharmaceuticals announces successful use of tegoprubart in kidney xenotransplant. Promising results show its potential to prevent rejection, marking a significant milestone in organ transplantation research.

Vandana Singh

Why Chewy Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares rose 58.9% to $0.3754 in pre-market trading. Airspan Networks recently reported new financing and leadership changes.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Eledon Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transpl...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eledon Pharma (ELDN) stock?

You can purchase shares of Eledon Pharma (NASDAQ:ELDN) through any online brokerage.

View our list of the best stock brokerages

Who are Eledon Pharma (ELDN) competitors?

Other companies in Eledon Pharma’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).

What is the target price for Eledon Pharma (ELDN) stock?

There is no analysis for Eledon Pharma.

What is the forecast for Eledon Pharma (ELDN) stock?

Eledon Pharma has a consensus price target of $15.25.

Current stock price for Eledon Pharma (ELDN)?

The stock price for Eledon Pharma (NASDAQ: ELDN) is $2.51 last updated June 28, 2024 at 5:10 PM EDT.

Does Eledon Pharma (ELDN) pay a dividend?

There are no upcoming dividends for Eledon Pharma.

When is Eledon Pharma (NASDAQ:ELDN) reporting earnings?

Eledon Pharma’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Eledon Pharma (ELDN) going to split?

There is no upcoming split for Eledon Pharma.

What sector and industry does Eledon Pharma (ELDN) operate in?

Eledon Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Eledon Pharma

Eledon Pharma (ELDN) Forecast